Clinical Trial Update: Hyperthermia European Adjuvant Trial [Phase 3]

View source ↗

Summary

A Phase 3 European adjuvant trial evaluating hyperthermia for resected pancreatic adenocarcinoma; current status is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Klinikum der Universitaet Muenchen, Grosshadern | Conditions: Resected Pancreatic Adenocarcinoma | Phase 3 | Status: UNKNOWN